DIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of Anteo Diagnostics Ltd is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The companys products comprise immunoassays, antibodies, instruments and RUO products. Its antibodies comprise osteocalcin, adrenocorticotropic hormone, adiponectin, aggrecan, calcitonin, alpha-fetoprotein, parathyroid hormone, carcino embryonic antigen, placental lactogen and thyroid stimulating hormone. DIAsources instruments comprise neptune instrument, automated system, ELISA reader, shaker, and washer. The company offers products in the fields of cardiovascular and salt balance, auto-immunity, gastrointestinal metabolism and fertility. It markets products in Belgium and abroad. DIAsource is headquartered in Louvain-La-Neuve, Belgium.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1149982
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company DIAsource ImmunoAssays SA
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1149982
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Mr. Nachiket Ghumare,
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @ http://bit.ly/1TBmnVG